Treating myopic foveoschisis

Article

Treating myopic foveoschisis

Vitreous cortex removal and internal limiting membrane (ILM) peeling could be critical in treating persistent myopic foveoschisis (MF), according to the results of a study published in the American Journal of Ophthalmology.

Kaori Sayanagi, Yasushi Ikuno and Yasuo Tano from Osaka University Medical School, Osaka, Japan, examined two highly myopic eyes of two patients with persistent MF after primary vitrectomy and gas tamponade. Both were then treated with pars plana vitrectomy, residual vitreous cortex removal, ILM peeling and long-term gas tamponade.In both cases total foveal reattachment was achieved in addition to improvements in best-corrected visual acuity.

The authors concluded that re-operation with vitreous cortex removal and ILM peeling could benefit patients with MF after their primary surgery. It also indicates that both treatments, if used in the first instance, could prevent the need for any re-operation at all.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.